Erectile dysfunction (ED) is a pretty common problem. It affects a large percentage of men all over the world. When you have ED, you can’t reliably get and keep an erection that’s firm enough for satisfying sex.
The numbers vary depending on age and other factors, but global estimates put ED rates between 10 and 20 percent. In the United States, about 52 percent of men between 40 and 70 years old report having ED. That number jumps to over 70 percent in men over 70.
The most common treatments right now are PDE5 inhibitors like Viagra and Cialis. These medications work for many men, but they’re not perfect. They only work for about 60 to 70 percent of men who try them. That leaves a large group of men looking for other options. Plus, some men experience side effects or can’t take PDE5 inhibitors because of other health conditions.
That’s why researchers are working hard to develop new ED therapies that work in different ways and meet the needs of more men. Some research focuses on the brain, while other research focuses on the tissues in the penis itself.
In this article, we’ll take a look at some of the most promising erectile dysfunction new drugs in development, including new PDE5 inhibitors, medications that work on the brain, medications that work on the penis, and even regenerative therapies.
Read more